{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:59:21Z","timestamp":1785283161219,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jdcr.2026.01.033","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:38:55Z","timestamp":1770050335000},"page":"42-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Bosutinib-induced palmoplantar keratoderma treated with acitretin"],"prefix":"10.1016","volume":"70","author":[{"given":"Ye","family":"Chua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Wiedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9413-3749","authenticated-orcid":false,"given":"Julie","family":"Mervak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthi","family":"Renati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jdcr.2026.01.033_bib1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1200\/JCO.2017.74.7162","article-title":"Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia: results from the randomized BFORE trial","volume":"36","author":"Cortes","year":"2018","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.jdcr.2026.01.033_bib2","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1182\/blood-2011-05-355594","article-title":"Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome\u2013positive chronic myeloid leukemia patients with resistance or intolerance to imatinib","volume":"118","author":"Cortes","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jdcr.2026.01.033_bib3","first-page":"160","article-title":"Bosutinib therapy in patients with chronic myeloid leukemia: practical considerations for management of side effects","volume":"7","author":"Ault","year":"2016","journal-title":"J Adv Pract Oncol"},{"issue":"5","key":"10.1016\/j.jdcr.2026.01.033_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/12034754211004560","article-title":"Drugs associated with the development of palmoplantar keratoderma: a systematic review","volume":"25","author":"Mirali","year":"2021","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.jdcr.2026.01.033_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2340\/00015555-0758","article-title":"Lichenoid drug eruption with palmoplantar hyperkeratosis due to imatinib mesylate: a case report and a review of the literature","volume":"90","author":"Kuraishi","year":"2010","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.jdcr.2026.01.033_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pharma.2016.12.006","article-title":"A case report of rare palmoplantar keratosis and nail dystrophy with imatinib","volume":"75","author":"Benabbes","year":"2017","journal-title":"Ann Pharm Fr"},{"issue":"3","key":"10.1016\/j.jdcr.2026.01.033_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70580","article-title":"Inflammatory\/immune adverse events in chronic myeloid leukemia patients during treatment with bosutinib","volume":"14","author":"Agostani","year":"2025","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.jdcr.2026.01.033_bib8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-199243040-00010","article-title":"Acitretin","volume":"43","author":"Pilkington","year":"1992","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.jdcr.2026.01.033_bib9","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/bjd.12519","article-title":"Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors","volume":"169","author":"Anforth","year":"2013","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2026.01.033_bib10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1365-2133.2006.07276.x","article-title":"Imatinib-associated lichenoid eruption: acitretin treatment allows maintained antineoplastic effect","volume":"154","author":"Dalmau","year":"2006","journal-title":"Br J Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626000512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626000512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:26:29Z","timestamp":1785281189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626000512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":10,"alternative-id":["S2352512626000512"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.01.033","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bosutinib-induced palmoplantar keratoderma treated with acitretin","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}